Malignancies represent the third leading cause of post-transplant mortality worldwide. The main challenge for transplant physicians is a timely diagnosis of this condition. The aim of the study was to identify a soluble diagnostic marker for monitoring the development of post-transplant malignancies.

Interleukin-27 is a potential marker for the onset of post-transplant malignancies / Pontrelli, P., Rascio, F., Zaza, G., Accetturo, M., Simone, S., Infante, B., Furian, L., Castellano, G., Ditonno, P., Battaglia, M., Cormio, L., Carrieri, G., Lupo, A., Rigotti, P., Gesualdo, L., Stallone, G., Grandaliano, G.. - In: NEPHROLOGY DIALYSIS TRANSPLANTATION. - ISSN 0931-0509. - 34:1(2018), pp. 157-166. [10.1093/ndt/gfy206]

Interleukin-27 is a potential marker for the onset of post-transplant malignancies

Rigotti, Paolo;
2018-01-01

Abstract

Malignancies represent the third leading cause of post-transplant mortality worldwide. The main challenge for transplant physicians is a timely diagnosis of this condition. The aim of the study was to identify a soluble diagnostic marker for monitoring the development of post-transplant malignancies.
2018
gene expression
immunology
interleukin-27
lymphomonocytes
post-transplant malignancies
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/20.500.11768/156944
Citazioni
  • ???jsp.display-item.citation.pmc??? 9
  • Scopus 11
  • ???jsp.display-item.citation.isi??? 9
social impact